Sanofi Profile



Odds of Distress

Check how we calculate scores
Equity ratings for Sanofi are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 19, 2019 and ending today August 18, 2019. Click here to learn more.
USD 0.37  0.89%

Sanofi Summary

Sanofi (SNY) is traded on BATS Exchange in USA and employs 104,226 people. The company currently falls under 'Mega-Cap' category with total capitalization of 105B. Sanofi runs under Healthcare sector within Drug Manufacturers - Major industry. The entity has 2.48B outstanding shares of which 2.62M shares are at this time shorted by investors with about 1.62 days to cover shorted positions. SANOFI-AVENTIS SA has about 8.73B in cash with 4.18B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.5.
Check Sanofi Probability Of Bankruptcy

Ownership Allocation (%)

Sanofi Target Price Odds Analysis

Odds Below 42.02HorizonTargetOdds Above 42.02
32.46%30 days 42.02 67.13%
Based on normal probability distribution, the odds of Sanofi to move above current price in 30 days from now is about 67.13% (This Sanofi probability density function shows the probability of Sanofi Stock to fall within a particular range of prices over 30 days) .

Sanofi Top Holders

Sanofi Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Dodge CoxCommon Shares60.7 M2.6 B
Fisher Asset Management LlcCommon Shares16.9 M729.9 M
View Sanofi Diagnostics

Sanofi Risk Profiles

Sanofi Key Fundamentals

Sanofi Against Markets

Sanofi Vital Trading Data

It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1 and Aubagio, an immunomodulatory and Lemtrada, a monoclonal antibody for multiple sclerosis. Sanofi was founded in 1973 and is headquartered in Paris, France. Sanofi is traded on BATS Exchange in USA. more
CEOOlivier BrandicourtView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 4 themes  View All
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock View All
Business Address54, Rue La Bo?tie
ExchangeBATS Exchange
IndustryDrug Manufacturers - Major
Phone33 1 53 77 40 00
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJuly 31, 2019

Sanofi Corporate Directors

Emmanuel Babeau Independent Director
Fabienne Lecorvaisier Director
Klaus Pohle Independent Director
Also please take a look at World Market Map. Please also try Watchlist Optimization module to optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm.